The Business Research Company’s global market reports are now updated with the latest market sizing
Read More
The Bayrab market is witnessing steady growth over the forecast period, supported by increasing stray animal populations, expansion of global vaccination coverage.
Read More
The Bayhep B market is witnessing steady growth over the forecast period, supported by growth in liver transplant procedures, increasing hepatitis screening rates.
Read More
The Baygam market is witnessing steady growth over the forecast period, supported by increasing animal bite incidents, expansion of vaccination programs.
Read More
The Elahere market is witnessing steady growth over the forecast period, supported by increasing adoption of precision oncology, growing use of biomarker testing.
Read More
The Egrifta (Tesamorelin Acetate) market is witnessing steady growth over the forecast period, supported by growth in personalized hiv care, pipeline expansion for peptide therapeutics.
Read More
The Ebanga market is witnessing steady growth over the forecast period, supported by growing demand for preventive migraine therapies, expanding biologics pipeline in neurology.
Read More
The Dysport market is witnessing steady growth over the forecast period, supported by rising demand for minimally invasive procedures, expanding therapeutic approvals.
Read More
The Dupixent market is witnessing steady growth over the forecast period, supported by expansion into new inflammatory conditions, rising biologics demand.
Read More
The Dukoral market is witnessing steady growth over the forecast period, supported by increasing global travel activity, climate change driven spread of cholera.
Read More
The Ducord market is witnessing steady growth over the forecast period, supported by growth in stem cell research funding, rising transplant success rates.
Read More